Focuses on regulation, safety, and pricing of drugs and devices.
What’s this subcategory for?
To discuss legislation on approvals, costs, and safety oversight.
How is it different?
It targets products specifically, not health systems or access.
What should posts include?
FDA oversight, pricing bills, safety recalls, and patent reform.
Why not merge?
Drug and device policy is highly technical and merits separate focus.
Engagement policy:
We welcome all viewpoints, as long as they are respectful. Keep the focus on policy and legislation, especially Congress. Avoid partisan debates about the presidency.